TY - JOUR T1 - Evidence of Protective Effect of Hydroxychloroquine on COVID-19 JF - The Journal of Rheumatology JO - J Rheumatol DO - 10.3899/jrheum.200638 SP - jrheum.200638 AU - Beuy Joob AU - Viroj Wiwanitkit Y1 - 2020/05/25 UR - http://www.jrheum.org/content/early/2020/06/09/jrheum.200638.abstract N2 - We would like to share ideas on the report “Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials”1. Balevic noted that “well-designed clinical trials that include patients with rheumatic disease are urgently needed to characterize the efficacy, safety, and target exposures for hydroxychloroquine1.” ER -